| [1] |
Lyu Y, Cheng Y, Wang B, et al. Comparison of the efficacy and safety of three endoscopic methods to manage large common bile duct stones: A systematic review and network meta-analysis[J]. J Laparoendosc Adv Surg Tech A, 2021, 31(4): 443-454.
|
| [2] |
Deng F, Zhou M, Liu PP, et al. Causes associated with recurrent choledocholithiasis following therapeutic endoscopic retrograde cholangiopancreatography: A large sample sized retrospective study[J]. World J Clin Cases, 2019, 7(9): 1028-1037.
|
| [3] |
Singh AN, Kilambi R. Single-stage laparoscopic common bile duct exploration and cholecystectomy versus two-stage endoscopic stone extraction followed by laparoscopic cholecystectomy for patients with gallbladder stones with common bile duct stones: systematic review and meta-analysis of randomized trials with trial sequential analysis[J]. Surg Endosc, 2018, 32(9): 3763-3776.
|
| [4] |
Kim DI, Kim MH, Lee SK, et al. Risk factors for recurrence of primary bile duct stones after endoscopic biliary sphincterotomy[J]. Gastrointest Endosc, 2001, 54(1): 42-48.
|
| [5] |
Ando T, Tsuyuguchi T, Okugawa T, et al. Risk factors for recurrent bile duct stones after endoscopic papillotomy[J]. Gut, 2003, 52(1): 116-121.
|
| [6] |
Parra-Membrives P, Martínez-Baena D, Lorente-Herce JM, et al. Choledocholithiasis recurrence following laparoscopic common bile duct exploration[J]. Cir Esp (Engl Ed), 2019, 97(6): 336-342.
|
| [7] |
Katsika D, Grjibovski A, Einarsson C, et al. Genetic and environmental influences on symptomatic gallstone disease: A Swedish study of 43 141 twin pairs[J]. Hepatology, 2005, 41(5): 1138-1143.
|
| [8] |
Buch S, Schafmayer C, Völzke H, et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease[J]. Nat Genet, 2007, 39(8): 995-999.
|
| [9] |
Buch S, Schafmayer C, Völzke H, et al. Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition[J]. Gastroenterology, 2010, 139(6): 1942-1951.
|
| [10] |
Rosmorduc O, Hermelin B, Boelle P Y, et al. ABCB4 gene mutation-associated cholelithiasis in adults[J]. Gastroenterology, 2003, 125(2): 452-459.
|
| [11] |
von Schönfels W, Buch S, Wölk M, et al. Recurrence of gallstones after cholecystectomy is associated with ABCG5/8 genotype[J]. J Gastroenterol, 2013, 48(3): 391-396.
|
| [12] |
Di Ciaula A, Garruti G, Frühbeck G, et al. The role of diet in the pathogenesis of cholesterol gallstones[J]. Curr Med Chem, 2019, 26(19): 3620-3638.
|
| [13] |
Tran ZV, Weltman A, Glass GV, et al. The effects of exercise on blood lipids and lipoproteins: A meta-analysis of studies[J]. Med Sci Sports Exerc, 1983, 15(5): 393-402.
|
| [14] |
Stokes CS, Gluud LL, Casper M, et al. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: A meta-analysis of randomized controlled trials[J]. Clin Gastroenterol Hepatol, 2014, 12(7): 1090-1100, e61.
|
| [15] |
Wang HH, Portincasa P, de Bari O, et al. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol[J]. Eur J Clin Invest, 2013, 43(4): 413-426.
|
| [16] |
Chen X, Yan XR, Zhang LP. Ursodeoxycholic acid after common bile duct stones removal for prevention of recurrence: A systematic review and meta-analysis of randomized controlled trials[J]. Medicine (Baltimore), 2018, 97(45): e13086.
|
| [17] |
Yamamoto R, Tazuma S, Kanno K, et al. Ursodeoxycholic acid after bile duct stone removal and risk factors for recurrence: A randomized trial[J]. J Hepatobiliary Pancreat Sci, 2016, 23(2): 132-136.
|
| [18] |
Muratori R, Mandolesi D, Pierantoni C, et al. Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: predictive factors[J]. Dig Liver Dis, 2017, 49(10): 1128-1132.
|
| [19] |
Fukuba N, Ishihara S, Sonoyama H, et al. Proton pump inhibitor is a risk factor for recurrence of common bile duct stones after endoscopic sphincterotomy-propensity score matching analysis[J]. Endosc Int Open, 2017, 5(4): E291-E296.
|
| [20] |
Ye C, Zhou W, Zhang H, et al. Alterations of the bile microbiome in recurrent common bile duct stone[J]. Biomed Res Int, 2020, 2020: 4637560.
|
| [21] |
Shen H, Ye F, Xie L, et al. Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria[J]. Sci Rep, 2015, 5: 17450.
|
| [22] |
Leung JW, Sung JY, Costerton JW. Bacteriological and electron microscopy examination of brown pigment stones[J]. J Clin Microbiol, 1989, 27(5): 915-921.
|
| [23] |
Leung JW, Yu AS. Hepatolithiasis and biliary parasites[J]. Baillieres Clin Gastroenterol, 1997, 11(4): 681-706.
|
| [24] |
Li X, Gao P. Hepatitis C virus infection increases risk of gallstone disease in elderly Chinese patients with chronic liver disease[J]. Sci Rep, 2018, 8(1): 4636.
|
| [25] |
Ueno N, Ozawa Y, Aizawa T. Prognostic factors for recurrence of bile duct stones after endoscopic treatment by sphincter dilation[J]. Gastrointest Endosc, 2003, 58(3): 336-340.
|
| [26] |
Pereira-Lima JC, Jakobs R, Winter UH, et al. Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence of biliary symptoms[J]. Gastrointest Endosc, 1998, 48(5): 457-464.
|
| [27] |
Park SY, Hong TH, Lee SK, et al. Recurrence of common bile duct stones following laparoscopic common bile duct exploration: A multicenter study[J]. J Hepatobiliary Pancreat Sci, 2019, 26(12): 578-582.
|
| [28] |
Song ME, Chung MJ, Lee DJ, et al. Cholecystectomy for prevention of recurrence after endoscopic clearance of bile duct stones in Korea[J]. Yonsei Med J, 2016, 57(1): 132-137.
|
| [29] |
Yoo ES, Yoo BM, Kim JH, et al. Evaluation of risk factors for recurrent primary common bile duct stone in patients with cholecystectomy[J]. Scand J Gastroenterol, 2018, 53(4): 466-470.
|
| [30] |
Jeon J, Lim SU, Park CH, et al. Restoration of common bile duct diameter within 2 weeks after endoscopic stone retraction is a preventive factor for stone recurrence[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(3): 251-256.
|
| [31] |
Murabayashi T, Kanno Y, Koshita S, et al. Long-term outcomes of endoscopic papillary large-balloon dilation for common bile duct stones[J]. Intern Med, 2020, 59(7): 891-899.
|
| [32] |
Keizman D, Shalom MI, Konikoff FM. An angulated common bile duct predisposes to recurrent symptomatic bile duct stones after endoscopic stone extraction[J]. Surg Endosc, 2006, 20(10): 1594-1599.
|
| [33] |
Zhang R, Luo H, Pan Y, et al. Rate of duodenal-biliary reflux increases in patients with recurrent common bile duct stones: evidence from barium meal examination[J]. Gastrointest Endosc, 2015, 82(4): 660-665.
|
| [34] |
Lobo DN, Balfour TW, Iftikhar SY, et al. Periampullary diverticula and pancreaticobiliary disease[J]. Br J Surg, 1999, 86(5): 588-597.
|
| [35] |
Li X, Zhu K, Zhang L, et al. Periampullary diverticulum may be an important factor for the occurrence and recurrence of bile duct stones[J]. World J Surg, 2012, 36(11): 2666-2669.
|
| [36] |
Kato S, Chinen K, Shinoura S, et al. Predictors for bile duct stone recurrence after endoscopic extraction for naïve major duodenal papilla: A cohort study[J]. PLoS One, 2017, 12(7): e180536.
|
| [37] |
Skar V, Skar AG, Osnes M. The duodenal bacterial flora in the region of papilla of Vater in patients with and without duodenal diverticula[J]. Scand J Gastroenterol, 1989, 24(6): 649-656.
|
| [38] |
Kim CW, Chang JH, Kim JH, et al. Size and type of periampullary duodenal diverticula are associated with bile duct diameter and recurrence of bile duct stones[J]. J Gastroenterol Hepatol, 2013, 28(5): 893-898.
|
| [39] |
Sugiyama M, Atomi Y. Risk factors predictive of late complications after endoscopic sphincterotomy for bile duct stones: long-term (more than 10 years) follow-up study[J]. Am J Gastroenterol, 2002, 97(11): 2763-2767.
|
| [40] |
Bove A, Bongarzoni G, Palone G, et al. Why is there recurrence after transcystic laparoscopic bile duct clearance? Risk factor analysis[J]. Surg Endosc, 2009, 23(7): 1470-1475.
|
| [41] |
Endo R, Satoh A, Tanaka Y, et al. Saline solution irrigation of the bile duct after stone removal reduces the recurrence of common bile duct stones[J]. Tohoku J Exp Med, 2020, 250(3): 173-179.
|
| [42] |
中华医学会消化内镜分会ERCP学组，胡冰，麻树人, 等. 内镜下逆行胆胰管造影术(ERCP)诊治指南(2010版)[J]. 中国继续医学教育, 2010, 2(6): 1-20.
|
| [43] |
Yasuda I, Fujita N, Maguchi H, et al. Long-term outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation for bile duct stones[J]. Gastrointest Endosc, 2010, 72(6): 1185-1191.
|
| [44] |
Doi S, Yasuda I, Mukai T, et al. Comparison of long-term outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation: A propensity score-based cohort analysis[J]. J Gastroenterol, 2013, 48(9): 1090-1096.
|
| [45] |
Kojima Y, Nakagawa H, Miyata A, et al. Long-term prognosis of bile duct stones: endoscopic papillary balloon dilatation versus endoscopic sphincterotomy[J]. Dig Endosc, 2010, 22(1): 21-24.
|
| [46] |
Tsujino T, Kawabe T, Komatsu Y, et al. Endoscopic papillary balloon dilation for bile duct stone: immediate and long-term outcomes in 1 000 patients[J]. Clin Gastroenterol Hepatol, 2007, 5(1): 130-137.
|
| [47] |
Mu H, Gao J, Kong Q, et al. Prognostic factors and postoperative recurrence of calculus following small-incision sphincterotomy with papillary balloon dilation for the treatment of intractable choledocholithiasis: A 72-month follow-up study[J]. Dig Dis Sci, 2015, 60(7): 2144-2149.
|
| [48] |
Li S, Su B, Chen P, et al. Risk factors for recurrence of common bile duct stones after endoscopic biliary sphincterotomy[J]. J Int Med Res, 2018, 46(7): 2595-2605.
|
| [49] |
Choi JH, Lee TY, Cheon YK. Effect of stent placement on stone recurrence and post-procedural cholangitis after endoscopic removal of common bile duct stones[J]. Korean J Intern Med, 2021, 36(Suppl 1): S27-S34.
|
| [50] |
Yang J, Peng JY, Pang EJ, et al. Efficacy of endoscopic nasobiliary drainage for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis after repeated clearance of common bile duct stones: experience from a Chinese center[J]. Dig Endosc, 2013, 25(4): 453-458.
|
| [51] |
Al-Habbal Y, Reid I, Tiang T, et al. Retrospective comparative analysis of choledochoscopic bile duct exploration versus ERCP for bile duct stones[J]. Sci Rep, 2020, 10(1): 14736.
|
| [52] |
Pan L, Chen M, Ji L, et al. The safety and efficacy of laparoscopic common bile duct exploration combined with cholecystectomy for the management of cholecysto-choledocholithiasis: An up-to-date meta-analysis[J]. Ann Surg, 2018, 268(2): 247-253.
|
| [53] |
Park BK, Seo JH, Jeon HH, et al. A nationwide population-based study of common bile duct stone recurrence after endoscopic stone removal in Korea[J]. J Gastroenterol, 2018, 53(5): 670-678.
|
| [54] |
Chang JH, Kim TH, Kim CW, et al. Size of recurrent symptomatic common bile duct stones and factors related to recurrence[J]. Turk J Gastroenterol, 2014, 25(5): 518-523.
|